New Warning Added to Avastin Cancer Drug

Genentech Inc., the maker of the cancer drug Avastin, had added a warning to their label stating a possible link between a brain condition and the use of the drug. The company states that less than .1% of patients have developed symptoms of reversible posterior leukoencephalopathy syndrome (RPLS).

Avastin is a monoclonal anti-body used to treat colon and rectal cancer. It is given by IV infusion, generally every two weeks.

If you are currently taking Avastin, talk to your doctor about the risk of developing RPLS. Although the risk is slight for most patients, it is a concern for many. More information about Avastin